Pulmonary Edema News and Research

RSS
Wyss Founding Director receives NC3Rs 3Rs Prize for Lung-on-a-Chip

Wyss Founding Director receives NC3Rs 3Rs Prize for Lung-on-a-Chip

EMA adopts positive opinion for Pfizer’s bosutinib conditional approval in the EU

EMA adopts positive opinion for Pfizer’s bosutinib conditional approval in the EU

No significant difference in patient outcomes with RBC transfusions using lower threshold levels

No significant difference in patient outcomes with RBC transfusions using lower threshold levels

Surgery poses cardiac risk to lupus women

Surgery poses cardiac risk to lupus women

Brain effects of high-altitude sickness retained long term

Brain effects of high-altitude sickness retained long term

Brain microhemorrhages more common among high altitude cerebral edema survivors

Brain microhemorrhages more common among high altitude cerebral edema survivors

Study analyzes effectiveness of ultrasonography in diagnosis and treatment of critical care patients

Study analyzes effectiveness of ultrasonography in diagnosis and treatment of critical care patients

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Pfizer receives FDA approval for BOSULIF to treat Ph+ chronic myelogenous leukemia

Greater awareness of MH and consequences of ryanodine receptor gene mutations

Greater awareness of MH and consequences of ryanodine receptor gene mutations

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

FDA approves Baxter's GAMMAGARD LIQUID for multifocal motor neuropathy

Merck announces data from ZOSTAVAX Phase III study on shingles

Merck announces data from ZOSTAVAX Phase III study on shingles

Mayo Clinic researchers join expedition to Everest

Mayo Clinic researchers join expedition to Everest

Scientist generates mutant version of IL-2 protein to treat advanced cancers

Scientist generates mutant version of IL-2 protein to treat advanced cancers

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Baxter to commence second GAMMAGARD LIQUID Phase III trial in Alzheimer's

Baxter submits GAMMAGARD LIQUID sBLA to FDA for treatment of MMN

Baxter submits GAMMAGARD LIQUID sBLA to FDA for treatment of MMN

Risk factors for acute mountain sickness

Risk factors for acute mountain sickness

Scientists identify how cells reduce tissue damage from inflammation in ALI model

Scientists identify how cells reduce tissue damage from inflammation in ALI model

Terrorist attacks with chemical weapons are a real possibility: Study

Terrorist attacks with chemical weapons are a real possibility: Study

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

Novartis to showcase 160 presentations on breast cancer, hematological disease drugs at SABCS and ASH

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain